Maintenance of ANCA Vasculitis Remission by Intermittent Rituximab Dosing
Clinical trial NCT02749292 · TERMINATED
Trial details
- NCT number
- NCT02749292
- Sponsor
- Massachusetts General Hospital
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2022-01-31
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.